J Cancer 2022; 13(4):1272-1281. doi:10.7150/jca.64996 This issue Cite

Research Paper

Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study

Solenne Le Louet1✉, Véronique Icart2, Marion Strullu3, Arnaud Petit4, Claire Freycon5, Pascale Blouin6, Jill Serre6, Nicolas Rama7, Yves Reguerre8, Christophe Piguet9, Marlène Pasquet10, Audrey David11, Pauline Simon12, Marilyne Poiree13, Liana Carausu14, Fanny Rialland15, Wadih Abouchahla16, Paul Saultier17, Stéphane Ducassou18, Julie Valduga19, André Baruchel3, Yves Bertrand1, Carine Domenech1,7

1. Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, University-Lyon1, Lyon, France
2. Department of Pediatric Ophtalmology, Hopital Nord Ouest de Villefranche sur Saône, Gleize, France
3. Department of Pediatric Hematology, Hôpital Robert-Debré, Paris, France
4. Department of Pediatric Hematology, Hôpital Armand-Trousseau, Paris, France
5. Department of Pediatric Hematology, CHU Grenoble Alpes, Grenoble, France
6. Department of Pediatric Hematology, CHRU de Tours, Tours, France
7. Apoptosis, Cancer and Development Laboratory - Center of Research of Cancerology of Lyon, INSERM U1052-CNRS UMR5286, Lyon, France
8. Department of Pediatric Hematology, Centre hospitalier Félix-Guyon, Saint Denis de La Réunion, France
9. Department of Pediatric Hematology, CHU de Limoges, Limoges, France
10. Department of Pediatric Hematology, CHU de Toulouse, Toulouse, France
11. Department of Pediatric Hematology, CHU de Saint Etienne, Saint Etienne, France
12. Department of Pediatric Hematology, CHU de Besançon, Besançon, France
13. Department of Pediatric Hematology, CHU de Nice, Nice, France
14. Department of Pediatric Hematology, CHU de Brest, Brest, France
15. Department of Pediatric Hematology, CHU de Nantes, Nantes, France
16. Department of Pediatric Hematology, CHU de Lille, Lille, France
17. Department of Pediatric Hematology, Hôpital de la Timone, Marseille, France
18. Department of Pediatric Hematology, CHU de Bordeaux, Bordeaux, France
19. Department of Pediatric Hematology, CHRU de Nancy, Nancy, France

Citation:
Le Louet S, Icart V, Strullu M, Petit A, Freycon C, Blouin P, Serre J, Rama N, Reguerre Y, Piguet C, Pasquet M, David A, Simon P, Poiree M, Carausu L, Rialland F, Abouchahla W, Saultier P, Ducassou S, Valduga J, Baruchel A, Bertrand Y, Domenech C. Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study. J Cancer 2022; 13(4):1272-1281. doi:10.7150/jca.64996. https://www.jcancer.org/v13p1272.htm
Other styles

File import instruction

Abstract

Graphic abstract

Ten to fifteen percent of children with acute lymphoblastic leukemia (ALL) relapse following treatment. Of these, less than 2% display ophthalmic relapses, which owing to their scarcity, are largely undocumented, leaving clinicians with few diagnostic and therapeutic recommendations, despite serious functional sequelae. We conducted a French multicenter retrospective study to collect all clinical, radiological, biological, and therapeutic data, and outcomes for children with ALL ophthalmic relapses. From 2000 to 2020, 20 ophthalmic relapses occurring after first-line therapy performed before January 1st, 2017 were included in our study: 14 B-ALL and 6 T-ALL. Fifteen patients (75%) had concomitant involvement of the central nervous system, and 11 (55%) a combined bone marrow relapse. Only 1 had an isolated ophthalmic relapse. Eight children (40%) died, 7 from a refractory disease and 1 from toxic death, and 4 patients relapsed. With a median follow-up of 63.1 months, 8 patients are currently alive in continuous complete remission with only 2 displaying severe ophthalmic sequelae. Although rare, ophthalmic relapse could have a significant impact on the functional prognosis of survivors. Their management must be multidisciplinary, with a central role given to ophthalmologists.

Keywords: Childhood, ophthalmic relapse, ALL


Citation styles

APA
Le Louet, S., Icart, V., Strullu, M., Petit, A., Freycon, C., Blouin, P., Serre, J., Rama, N., Reguerre, Y., Piguet, C., Pasquet, M., David, A., Simon, P., Poiree, M., Carausu, L., Rialland, F., Abouchahla, W., Saultier, P., Ducassou, S., Valduga, J., Baruchel, A., Bertrand, Y., Domenech, C. (2022). Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study. Journal of Cancer, 13(4), 1272-1281. https://doi.org/10.7150/jca.64996.

ACS
Le Louet, S.; Icart, V.; Strullu, M.; Petit, A.; Freycon, C.; Blouin, P.; Serre, J.; Rama, N.; Reguerre, Y.; Piguet, C.; Pasquet, M.; David, A.; Simon, P.; Poiree, M.; Carausu, L.; Rialland, F.; Abouchahla, W.; Saultier, P.; Ducassou, S.; Valduga, J.; Baruchel, A.; Bertrand, Y.; Domenech, C. Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study. J. Cancer 2022, 13 (4), 1272-1281. DOI: 10.7150/jca.64996.

NLM
Le Louet S, Icart V, Strullu M, Petit A, Freycon C, Blouin P, Serre J, Rama N, Reguerre Y, Piguet C, Pasquet M, David A, Simon P, Poiree M, Carausu L, Rialland F, Abouchahla W, Saultier P, Ducassou S, Valduga J, Baruchel A, Bertrand Y, Domenech C. Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study. J Cancer 2022; 13(4):1272-1281. doi:10.7150/jca.64996. https://www.jcancer.org/v13p1272.htm

CSE
Le Louet S, Icart V, Strullu M, Petit A, Freycon C, Blouin P, Serre J, Rama N, Reguerre Y, Piguet C, Pasquet M, David A, Simon P, Poiree M, Carausu L, Rialland F, Abouchahla W, Saultier P, Ducassou S, Valduga J, Baruchel A, Bertrand Y, Domenech C. 2022. Novel Insights into Pediatric Acute Lymphoblastic Leukemia Ophthalmic Relapses from a Nationwide Cohort Study. J Cancer. 13(4):1272-1281.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.